Real-time enrollment status for this rheumatoid arthritis clinical trial
Current Status
Completed
Checked: June 1, 2026 at 8:31 PM UTC
| NCT Number | NCT05848258 |
| Recruiting Status | Completed |
| Condition | Rheumatoid Arthritis |
| Phase | Clinical Trial |
| Target Enrollment | 380 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | May 22, 2026 (1 week ago) |
As of June 1, 2026: Clinical trial NCT05848258 is currently completed participants. This clinical trial study for rheumatoid arthritis is not currently accepting new participants at 12 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05848258 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05848258 was last updated 1 week ago (May 22, 2026). HelloStudys verifies this status automatically.